Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Genrui Biotech Inc.

Genrui Biotech Inc., founded in 2004, specializes in the development, manufacturing, and marketing of in vitro diagno... read more Featured Products: More products

Download Mobile App





Genrui Biotech Showcases Range of Clinical Diagnostic Instruments at MEDICA 2026

By LabMedica International staff writers
Posted on 17 Nov 2026

Genrui Biotech (Shenzhen, China) is showcasing its clinical diagnostic instruments at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. More...

Among the featured products are the KT-8000 five-part differential hematology analyzer, FA50, FA30, and FA20 quantitative immunoassay analyzers, and PA240 fully automated specific protein analyzer. These instruments support hematology, point-of-care testing, immunoassays, and specific protein measurement.

Among the featured products is the KT-8000 5-Diff Hematology Analyzer, a fully automated system equipped with an automatic sample loader and mixer to reduce manual handling and extend walk-away time. The analyzer incorporates a smart counting mode, supports both open-vial and automatic loading modes, and allows priority processing of emergency samples. An integrated data management system helps streamline laboratory workflows.

Genrui is also presenting its FA50 quantitative immunofluorescence analyzer, a point-of-care testing (POCT) system suitable for clinics, physicians' offices, and hospital departments such as intensive care units. The analyzer supports whole blood, serum, and plasma samples and features magnetic card-based automatic calibration. Another featured product is the FA30, which offers 12 independent testing channels with individual temperature control, a 10.1-inch touchscreen, and a maintenance-free design without internal liquid pathways. The system is intended for medium-sized laboratories processing approximately 30 samples daily.

The company is also highlighting the FA20, a compact, portable quantitative immunoassay analyzer that supports fingerstick blood testing and delivers results in approximately 3 or 10 minutes, depending on the assay. It uses disposable consumables to minimize cross-contamination and features magnetic card calibration and a rechargeable lithium battery supporting up to 10 hours of continuous operation.

Also featured is the PA240 Fully-Auto Specific Protein Analyzer, which combines colorimetry and nephelometry to support testing across clinical areas such as renal function, rheumatology, immunoglobulins, inflammation, and glucose metabolism. Its dual-method approach expands the assay menu to accommodate different laboratory requirements. These instruments form part of Genrui's broader portfolio of automated and point-of-care diagnostic technologies.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.